Which isn’t much. I put that out there so others won’t have to.

I also make that disclaimer in advance of what is a grander, more important topic: To what extent is the so-called "Googlization of reality" affecting our understanding of the world around us? The answer may not be so available and everybody with a stake in it will give you different answers.

If you took the Internet’s word for everything, you might believe that Ron Paul is a Republican frontrunner or that the elephant population has tripled in the past six months (see Stephen Colbert’s "wikiality" social experiment).

Clearly, information on the Internet (even Google) isn’t perfect, and knowing your source is paramount, hence my opening disclaimer.

The Center for Medicine in the Public Interest (CMPI) is a medical industry thinktank, fronted by former Bush Administration FDA officials. CMPI released a study this week outlining the perils of relying on Google for prescription medication information.

“What we found was not only disturbing, but dangerous to public health,” said CMPI vice president Robert Goldberg. “For millions of Americans, Google has replaced the family physician. People trust, and make decisions, based on the information they find online. With few exceptions, the information we found appeared legitimate but had no medical authority whatsoever. In many cases, we found lawyers posing as medical experts.”   

For searches on keywords like "Crestor side effects" and "Avandia side effects" CMPI found:

• 65% of the first three pages of search results came from sites which were biased or contained unverified information.
• Almost half of the first three pages of search results belonged to lawyers and attorney referral services seeking plaintiffs for class action lawsuits.
• Zero official regulatory pages or professional medical organizations appeared in the inventory of results.

Crestor is a cholesterol medication made by AstraZeneca and Avandia is a type 2 diabetes drug produced by GlaxoSmithKline.

Many of the results also referred to "unmoderated" patient forums, sites selling or promoting "alternative medicines" or were sites run by, as CMPI describes them, "anti-pharmaceutical activists."

All of these concerns and findings are published in a 33-page paper entitled "Insta-Americans: The Empowered (and Imperiled) Health Care Consumer in the Age of Internet Medicine." Similar concerns were voiced about selective serotonin reuptake inhibitors and their (Internet) relationship to teen suicide rates and links between vaccinations and autism.

"Much like our email boxes are filled by ‘spam’ urging us to collect millions from Nigeria or confirm our banking information from phony Ebay or Bank of America security sites, a lot of the medical ‘information’ on the Web is designed to sell, deceive or frighten, rather than inform," said Goldberg.

Citing a Pew report, CMPI 113 million Americans search for health information, but three quarters rarely check the sources of the information.

According to Peter Pitts, CMPI President and former Associate Commissioner for External Affairs for the FDA, "it is important to remember that not everything online is true. The Internet has made it easier than ever before for charlatans and quacks to spread fear and misinformation. Mark Twain wrote: ?’Beware of health books. You might die of a misprint.’ The same can now be said of the Web."

And that can really affect pharmaceutical sales. Because doctors were afraid of lawsuits and patients were afraid of, you know, death, Avandia prescriptions had declined by 60 percent as September 2007.

Of course, it could also have something to do with the black box warning the FDA put on Avandia about increased heart problems. If you use a less targeted keyword, like simply "avandia," you’ll find that official government warning (and one for Crestor, too), along with official pharmaceutical company pages, scores of lawyer-sponsored AdWords links, pages from WebMD, the Mayo Clinic, the New York Times, USA Today, and a group called Public Citizen which runs a site called WorstPills.org.

Pitts and Goldberg aren’t especially fond of that last group, and single out Dr. Sidney Wolfe, who runs the site, as a source of misinformation about Avandia. Wolfe joins several others with lots of letters behind their names on the site’s About page. Maybe it’s because Wolfe has a close relationship with Ralph Nader, that CMPI labels them an anti-pharmaceutical activist group. Who knows?

But Wolfe’s opinion of Avandia match a Cleveland Clinic doctor named Stephen Nissen, whose May 2007 New England Journal of Medicine article about the drug CMPI cites as a "common source of misinformation." Dr. Nissen’s viewpoint however is echoed by a Toronto endocrinologist in this more recent (December 2007) USA Today article.

So why fixate on these drugs in particular? You could present a number of theories. CMPI is partially funded by the pharmaceutical industry, the Lilly Endowment (connected to Eli Lilly) being one of the largest contributors. Patients shying away from pharmaceuticals is bad for business.

A clue could be in reporter Evelyn Pringle’s article about Avandia, the FDA and CMPI. Pringle labels CMPI as "a home for industry hit men who served in the Bush Administration’s FDA." Pringle explains in detail Pitts’ and Goldberg’s association with Manning, Selvege & Lee, a PR firm representing many pharmaceutical companies, including AstraZeneca, and with FDA spokesman Douglas Arbesfeld, who has a close relationship with GSK.

But I’m sure that has nothing to do with their opinion on what is misinformation and what isn’t.

The extra-cynical of us might also notice CMPI’s definite stance against regulation of the health care industry and any type of universal health care. Those cynics might get really crazy and suggest that by advocating a greater reliance on your doctor and the drugs he or she prescribes rather than moonbat alternatives cuts down on the perception that there are flaws in the health care industry in its current privatized state. Plus, with obesity rates the way they are, diabetes medicines are big, big money.

But that’s just crazy right?

Well, anyway, CMPI says to check your sources, especially those sources found on Google, the nation’s most popular search engine, where most online health research begins. Sometimes people manipulate the information to suit them.   
 

But you might also conclude that a variety of sources is a good thing. I could be wrong. After all, I did all my research for this article on Google.

“YouTube Gives Straight Dope On Big Pharma”

Whatever YouTube was worth in dollars to Google, multiply that value by the earnestness with which the public is using the site to create their own expository media. AdAge calls them "budding Michael Moores."

If your politics don’t allow for Michael Moore love, choose a documentarian you can sink your teeth into.

It’s exciting enough to see the realization of the Citizen Press, which is in the end YouTube’s and the blogosphere’s greatest gift to the public, but it is dizzying to think that pharmaceutical companies, those Goliaths, are worried about little ol’ me and you, and the damage we can inflict with a keyboard and digital camera.

Rich Thomaselli says the FDA and Congress aren’t as frightening as YouTube – most likely because there is no lobby outside the halls of a website, no fine dining or dinner jackets, no trips to hot spring resorts.

Better, with YouTube, you can upload your message and wait for light bulbs without having to go through the gated media community with its own agendas and entangling alliances. Your message – so long as it doesn’t interfere with the RIAA, it would seem – is broadcast loud and clear.

And now, former pharmaceutical sales representatives are returning spoonfuls of medicine, sans the sugar, to their previous employers via video messages on YouTube. This Eli Lilly rep, for example, notes part of his job description:

"We were instructed by our camps to downplay those side effects and to focus on the efficacies of the drug."

The drug he speaks of in this confession is Zyprexa, which was causing a large number of patients to "blimp up," possibly increasing instances of diabetes.   

Of course, what can be used for good can also be used for…well, counter-arguments. Nothing bars Big Pharma from producing their own positively spun messages on YouTube as well.

And they’ve got a nice budget for video advertising, thanks to Congress allowing TV ads at this millennium’s start, and thanks to doctors and you and me for paying the pusher what he wants at the pick-up counter. We’re paying for their advertising – nice of us, isn’t it?
  
  

Samaritan Pharmaceuticals, Inc. is a development stage biotechnology company engaged in the research and development of novel therapeutic and diagnostic products to treat chronic debilitating diseases such as Alzheimer’s, Cancer, central nervous system disorders, cardiovascular disease and HIV.

“We are pleased to welcome Samaritan Pharmaceuticals to the American Stock Exchange,” said John McGonegal, senior vice president of the Amex Equities Group. “Samaritan is an innovator within the biotechnology industry and we look forward to working with them to increase investor attention and provide the support a growing company needs in today’s competitive marketplace.”

Samaritan President and CEO Janet Greeson stated, “By being listed on the Amex, Samaritan hopes to achieve greater accessibility to the institutional investment community; improved share price stability and liquidity; and broader investor awareness.” Samaritan CFO Eugene Boyle further stated, “Our listing on the Amex opens a new chapter in Samaritan’s history and is a major part of our strategy to attract new investors and increase the visibility of Samaritan.”